{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:48:58Z","timestamp":1784551738118,"version":"3.55.0"},"reference-count":17,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2024,8,5]]},"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1136\/ejhpharm-2023-004075","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T13:20:17Z","timestamp":1724505617000},"page":"488-490","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease"],"prefix":"10.1136","volume":"32","author":[{"given":"Rebeca","family":"A\u00f1ez-Casta\u00f1o","sequence":"first","affiliation":[{"name":"Department of Hospital Pharmacy, Reina Sofia University General Hospital, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3950-7250","authenticated-orcid":false,"given":"Carles","family":"Iniesta-Naval\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Reina Sofia University General Hospital, Murcia, Spain"},{"name":"Clinical Pharmacokinetics and Applied Pharmacotherapy Group, Instituto Murciano de Investigaci\u00f3n Biosanitaria (IMIB-Pascual Parrilla), El Palmar, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Almanchel-Rivadeneyra","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Reina Sofia University General Hospital, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Garc\u00eda-Villalba","sequence":"additional","affiliation":[{"name":"Department of Infectous Disease, Reina Sofia University General Hospital, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Oliver-Galera","sequence":"additional","affiliation":[{"name":"Department of Infectous Disease, Reina Sofia University General Hospital, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Rentero-Redondo","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Reina Sofia University General Hospital, Murcia, Spain"},{"name":"Clinical Pharmacokinetics and Applied Pharmacotherapy Group, Instituto Murciano de Investigaci\u00f3n Biosanitaria (IMIB-Pascual Parrilla), El Palmar, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"key":"2025082102102329000_32.5.488.1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.1.219"},{"key":"2025082102102329000_32.5.488.2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku260"},{"key":"2025082102102329000_32.5.488.3","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1038\/psp.2013.76","article-title":"Population pharmacokinetics of inhaled tobramycin powder in cystic fibrosis patients","volume":"3","author":"Ting","year":"2014","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"2025082102102329000_32.5.488.4","doi-asserted-by":"publisher","DOI":"10.5414\/CNP66464"},{"key":"2025082102102329000_32.5.488.5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1130-6343(08)72823-X","article-title":"Recomendaciones para la monitorizaci\u00f3n de antibi\u00f3ticos en pacientes cr\u00edticos ingresados en UCI","volume":"32","author":"Alvarez","year":"2008","journal-title":"Farm Hosp"},{"key":"2025082102102329000_32.5.488.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2004.05.008"},{"key":"2025082102102329000_32.5.488.7","first-page":"101584","article-title":"Exacerbation of chronic renal failure because of inhaled tobramycin in a lung transplant patient","volume":"36","author":"Mora Cuesta","year":"2022","journal-title":"Respir Med Case Rep"},{"key":"2025082102102329000_32.5.488.8","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.healun.2005.10.008","article-title":"Renal toxicity due to inhaled tobramycin in lung transplant recipients","volume":"25","author":"Laporta","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"2025082102102329000_32.5.488.9","first-page":"451","article-title":"Therapeutic Drug Monitoring of Inhaled Tobramycin in a Post-Hematopoietic Cell Transplant Patient With Bronchiolitis Obliterans and End-Stage Renal Disease","volume":"25","author":"Trone","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2025082102102329000_32.5.488.10","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.4.543.32122"},{"key":"2025082102102329000_32.5.488.11","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000202126.44544.41"},{"key":"2025082102102329000_32.5.488.12","doi-asserted-by":"publisher","DOI":"10.4065\/79.9.1185"},{"key":"2025082102102329000_32.5.488.13","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060196"},{"key":"2025082102102329000_32.5.488.14","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp100683"},{"key":"2025082102102329000_32.5.488.15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/antibiotics10040424","article-title":"Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in A Cystic Fibrosis Patient","volume":"10","author":"Miller","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"2025082102102329000_32.5.488.16","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.10185"},{"key":"2025082102102329000_32.5.488.17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/jac\/dkac412","article-title":"Incidence and associated risk factors for systemic drug levels with inhaled aminoglycoside therapy","volume":"78","author":"Schultheis","year":"2023","journal-title":"J Antimicrob Chemother"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2023-004075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T09:10:42Z","timestamp":1755767442000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2023-004075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,24]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,8,21]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/ejhpharm-2023-004075"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2023-004075","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,24]]}}}